TAPI-2 from Santa Cruz Biotechnology, Inc.

Product Specs
ItemTAPI-2
CompanySanta Cruz Biotechnology, Inc.
Price $280.00Supplier Page View Company Product Page
Catalog Numbersc-205851
Quantity1 mg
TypeBiochemical Reagents
Molecular Weight415.53

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Beta1-Adrenergic Receptor Cleavage and Regulation by ElastaseJACC: Basic to Translational ScienceAugust 1, 2023Jing Zhu, Susan F. Steinbergtheophylline (Cat# T1633) were from Sigma-Aldrich. MMP-2/MMP-3 inhibitor I (Cat# sc-295483) and TAPI-2 (Cat# sc-205851) were from Santa Cruz Biotechnology. GW280264X (ADAM-10/ADAM-17 inhibitor, Cat# 7030) was from AOBIOUS

(2) HIV-1 release requires Nef-induced caspase activationPloS oneJanuary 1, 2023Segura J, Ireland J, Zou Z, Roth G, Buchwald J, Shen TJ, Fischer E, Moir S, Chun TW, Sun PD.

(3) Immunomodulatory receptor VSIG4 is released during spontaneous bacterial peritonitis and predicts short-term mortalityJHEP reports : innovation in hepatologyJanuary 1, 2022Reißing J, Lutz P, Frissen M, Ibidapo-Obe O, Reuken PA, Wirtz TH, Stengel S, Quickert S, Rooney M, Große K, et al.

(4) β(1)-adrenergic receptor N-terminal cleavage by ADAM17; the mechanism for redox-dependent downregulation of cardiomyocyte β(1)-adrenergic receptorsJournal of molecular and cellular cardiologyMay 1, 2021Zhu J, Steinberg SF.

(5) The N-terminus of GPR37L1 is proteolytically processed by matrix metalloproteasesScientific reportsNovember 17, 2020Coleman JLJ, Ngo T, Smythe RE, Cleave AJ, Jones NM, Graham RM, Smith NJ.

(6) Cyclosporin A activates human hepatocellular carcinoma (HepG2 cells) proliferation: implication of EGFR-mediated ERK1/2 signaling pathwayNaunyn-Schmiedeberg's archives of pharmacologyMay 1, 2020Abo-El Fetoh ME, Helal GK, Saleh IG, Ewees M, ElShafey M, Elnagar MR, Akool ES.

(7) ADAM10 and ADAM17 cleave PD-L1 to mediate PD-(L)1 inhibitor resistanceOncoimmunologyJanuary 1, 2020Orme JJ, Jazieh KA, Xie T, Harrington S, Liu X, Ball M, Madden B, Charlesworth MC, Azam TU, Lucien F, et al.

(8) HIV-1 targets L-selectin for adhesion and induces its shedding for viral releaseNature communicationsJuly 19, 2018Kononchik J, Ireland J, Zou Z, Segura J, Holzapfel G, Chastain A, Wang R, Spencer M, He B, Stutzman N, et al.

(9) Prostaglandin J2 promotes O-GlcNAcylation raising APP processing by α- and β-secretases: relevance to Alzheimer's diseaseNeurobiology of agingFebruary 1, 2018Jean-Louis T, Rockwell P, Figueiredo-Pereira ME.

(10) Angiotensin type 2 receptor activation promotes browning of white adipose tissue and brown adipogenesisSignal transduction and targeted therapyJanuary 1, 2017Than A, Xu S, Li R, Leow MK, Sun L, Chen P.

(11) ADAM10 mediates the house dust mite-induced release of chemokine ligand CCL20 by airway epitheliumAllergyDecember 1, 2015Post S, Rozeveld D, Jonker MR, Bischoff R, van Oosterhout AJ, Heijink IH.

(12) Latent HIV-1 is activated by exosomes from cells infected with either replication-competent or defective HIV-1RetrovirologyOctober 26, 2015Arenaccio C, Anticoli S, Manfredi F, Chiozzini C, Olivetta E, Federico M.

(13) Calcyon stimulates neuregulin 1 maturation and signalingMolecular psychiatryOctober 1, 2015Yin DM, Chen YJ, Liu S, Jiao H, Shen C, Sathyamurthy A, Lin TW, Xiong WC, Li BM, Mei L, et al.

(14) Hypercapnia attenuates ventilator-induced lung injury via a disintegrin and metalloprotease-17The Journal of physiologyOctober 15, 2014Otulakowski G, Engelberts D, Gusarova GA, Bhattacharya J, Post M, Kavanagh BP.

(15) Exosomes from human immunodeficiency virus type 1 (HIV-1)-infected cells license quiescent CD4+ T lymphocytes to replicate HIV-1 through a Nef- and ADAM17-dependent mechanismJournal of virologyOctober 1, 2014Arenaccio C, Chiozzini C, Columba-Cabezas S, Manfredi F, Affabris E, Baur A, Federico M.

(16) Cell activation and HIV-1 replication in unstimulated CD4+ T lymphocytes ingesting exosomes from cells expressing defective HIV-1RetrovirologyJune 12, 2014Arenaccio C, Chiozzini C, Columba-Cabezas S, Manfredi F, Federico M.

Be the First to Write a Review!

TAPI-2 Chemicals

TAPI-2 from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (16)

Reviews

TAPI-2 from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map